Grail (NASDAQ:GRAL) Trading 9.2% Higher – Here’s What Happened

Grail, Inc. (NASDAQ:GRAL)’s stock price rose 9.2% on Tuesday . The stock traded as high as $18.65 and last traded at $19.02. Approximately 79,081 shares traded hands during mid-day trading, a decline of 88% from the average daily volume of 661,364 shares. The stock had previously closed at $17.42.

Wall Street Analyst Weigh In

Several research analysts have commented on the stock. Morgan Stanley assumed coverage on shares of Grail in a research report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 target price for the company. Wolfe Research started coverage on Grail in a report on Friday, November 15th. They issued a “peer perform” rating for the company. Finally, Guggenheim initiated coverage on Grail in a research report on Thursday, October 17th. They issued a “neutral” rating on the stock.

Grail Trading Up 6.1 %

The stock has a fifty day moving average price of $18.36.

Insider Activity

In other news, CFO Aaron Freidin sold 30,452 shares of the business’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $14.02, for a total value of $426,937.04. Following the sale, the chief financial officer now owns 268,277 shares of the company’s stock, valued at approximately $3,761,243.54. The trade was a 10.19 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Institutional Investors Weigh In On Grail

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Douglas Lane & Associates LLC acquired a new stake in shares of Grail during the fourth quarter worth $3,034,000. A. D. Beadell Investment Counsel Inc. purchased a new stake in shares of Grail during the fourth quarter worth $430,000. FNY Investment Advisers LLC acquired a new stake in shares of Grail during the 4th quarter valued at about $26,000. 180 Wealth Advisors LLC acquired a new stake in Grail in the fourth quarter valued at approximately $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management bought a new stake in Grail in the fourth quarter worth $387,000.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.